Search Results - Drugs

Cancer drug design and discovery by Neidle, Stephen

An electronic book accessible through the World Wide Web; click to view

Management of generic drug development challenges and opportunities /

Table of Contents: “…Contents: Generic drugs -- Project management -- Indian perspective -- Generics production and sales -- Patent cliff -- Quality by design -- Product pricing -- Drug launch time -- Lifecycle management -- Market penetration -- Cost management -- Scope creep -- Project management -- Cross-cultural communication.…”
Get full text

Development of a cancer drug

Table of Contents: “…Contents: Requirements for drug approval in the U.S. -- Legal evolution of drug approval -- The FDA and oncology drugs -- Clinical trial phases -- The effectiveness requirement -- Traditional and new approaches to trial design -- Types of controls -- Targeted therapies -- Companion diagnostics -- Endpoints for oncology trials -- Types of drug approval -- New drug application (NDA) -- Biomarkers -- FDA reviews and approvals.…”
Get full text
Series

Drug delivery for cancer therapeutics

Table of Contents: “…Contents: Cancer therapeutics -- Drug delivery mechanisms -- Drug development -- Liposomes -- Nanoparticles -- Nanotechnology -- Nanotoxicology -- Niosomes -- Dendrimers -- Micelles -- Routes of drug delivery.…”
Get full text
Series

Drug delivery for cancer therapeutics

Table of Contents: “…Contents: Cancer therapeutics -- Drug delivery mechanisms -- Drug development -- Liposomes -- Nanoparticles -- Nanotechnology -- Nanotoxicology -- Niosomes -- Dendrimers -- Micelles -- Routes of drug delivery.…”
Get full text
Series

Development of a cancer drug

Table of Contents: “…Contents: Requirements for drug approval in the U.S. -- Legal evolution of drug approval -- The FDA and oncology drugs -- Clinical trial phases -- The effectiveness requirement -- Traditional and new approaches to trial design -- Types of controls -- Targeted therapies -- Companion diagnostics -- Endpoints for oncology trials -- Types of drug approval -- New drug application (NDA) -- Biomarkers -- FDA reviews and approvals.…”
Get full text
Series

Management of generic drug development challenges and opportunities /

Table of Contents: “…Contents: Generic drugs -- Project management -- Indian perspective -- Generics production and sales -- Patent cliff -- Quality by design -- Product pricing -- Drug launch time -- Lifecycle management -- Market penetration -- Cost management -- Scope creep -- Project management -- Cross-cultural communication.…”
Get full text

Current trends in antiviral drug development

Subjects: Get full text
Series (Antivirals)
Series (Small molecule drug discovery)

Strengths and limitations of phenotypic drug discovery

Table of Contents: “…Contents: Why we need new antibiotics -- Different approaches to drug discovery -- Phenotypic drug discovery -- Limitations of phenotypic drug discovery.…”
Get full text

Current trends in antiviral drug development

Subjects: Get full text
Series (Antivirals)
Series (Small molecule drug discovery)

Current trends in antiviral drug development

Subjects: Get full text
Series (Antivirals)
Series (Small molecule drug discovery)

Strengths and limitations of phenotypic drug discovery

Table of Contents: “…Contents: Why we need new antibiotics -- Different approaches to drug discovery -- Phenotypic drug discovery -- Limitations of phenotypic drug discovery.…”
Get full text

Federal agency roles in cancer drug development from preclinical research to new drug approval the National Cancer Institute and the Food and Drug Administration / by Newhouse, Joseph P.

An electronic book accessible through the World Wide Web; click to view

A systems biology approach to drug development clinical testing of biomarkers for the anti-ErbB3 antibody MM-121 /

Table of Contents: “…Contents: Oncology drug development -- Network biology -- The HRG family of ligands -- The ErbB pathway -- MM-121 mechanism of action -- Data from in-vitro and iv-vivo experiments using MM-121 -- Timeline of MM-121: 2003-2015.…”
Get full text
Series

Strategies for discovering new antibiotics

Table of Contents: “…Contents: The history of antibiotics -- Antibiotic resistance -- Antibiotic development -- The need for new antibiotics -- The antibiotic golden age -- Target to drug and drug to target strategies -- Challenges in antibiotic development -- The future of antibiotic discovery.…”
Get full text

Strategies for discovering new antibiotics

Table of Contents: “…Contents: The history of antibiotics -- Antibiotic resistance -- Antibiotic development -- The need for new antibiotics -- The antibiotic golden age -- Target to drug and drug to target strategies -- Challenges in antibiotic development -- The future of antibiotic discovery.…”
Get full text

Regulatory considerations for vaccine development, talk 1 chemistry, manufacturing and control /

Table of Contents: “…Contents: Functions of the FDA/CBER/OVRR -- Definition and types of vaccines -- Evolution & legal framework for vaccine regulations -- Drug substance and product -- CMC development -- Vaccine manufacturing -- Preclinical evaluation -- Process validation -- Novel technologies.…”
Get full text
Series

Regulatory considerations for vaccine development, talk 2 clinical regulatory considerations (part 1 of 2) /

Table of Contents: “…Contents: Investigational New Drug (IND) regulations -- Key clinical development milestones -- Safety and efficacy concepts: a regulator's perspective.…”
Get full text
Series

Regulatory considerations for vaccine development, talk 2 clinical regulatory considerations (part 2 of 2) /

Subjects: “…United States. Food and Drug Administration.…”
Get full text
Series

Animal models of seizures and epilepsy

Table of Contents: “…Contents: Diverse models available -- Invaluable preclinical approach for discovery of new treatments for epilepsy -- Specific models for pharmacoresistant seizures -- Models for the discovery of epilepsy-preventing drugs.…”
Get full text
Series (Animal models in biomedical research)
Series (Epilepsy and seizures)